US regulators approve Wegovy pill for weight loss
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
All Stories
Big retailers didn’t pull ByHeart baby formula fast enough after botulism recall, FDA says
Four of the nation’s top retail stores failed to promptly pull contaminated infant formula tied to a dangerous botulism outbreak from their shelves, federal health officials said in warning letters...
Botulism outbreak sickens more than 50 babies and expands to all ByHeart products
Federal health officials on Wednesday expanded an outbreak of infant botulism tied to recalled ByHeart baby formula to include all illnesses reported since the company began production in March 2022.
ByHeart baby formula from all lots may be contaminated with botulism bacteria, tests show
Tests of ByHeart infant formula tied to a botulism outbreak that has sickened dozens of babies showed that all of the company’s products may have been contaminated.
Babies who drank ByHeart formula got sick months before botulism outbreak, parents say
Officials said six babies who consumed ByHeart formula were treated for botulism between November 2024 and June 2025, months before the reported outbreak.
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the recalled product on some store shelves.
A baby formula recall linked to an infant botulism outbreak is expanding. Here’s what to know.
ByHeart, which makes organic infant formula, recalled all of its products sold throughout the U.S. on Tuesday amid a growing outbreak of infant botulism.
Preliminary tests find germ that causes botulism in ByHeart baby formula
Preliminary tests showed that ByHeart baby formula contained the type of bacteria that produces the toxin linked to a botulism outbreak, California health officials said.
Trump unveils deal to expand coverage and lower costs on obesity drugs
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
Advice to feed babies peanuts early and often helped thousands of kids avoid allergies
A decade after a landmark study proved that feeding peanut products to young babies could prevent development of life-threatening allergies, new research finds the change has made a big difference...